SG Americas Securities’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $632K | Buy |
70,160
+9,908
| +16% | +$156K | ﹤0.01% | 2049 |
|
|
2025
Q4 | $1.1M | Buy |
+60,252
| New | +$1.02M | ﹤0.01% | 1936 |
|
|
2025
Q3 | – | Sell |
-9,031
| Closed | -$164K | – | 3354 |
|
|
2025
Q2 | $164K | Buy |
9,031
+419
| +5% | +$8.54K | ﹤0.01% | 2381 |
|
|
2025
Q1 | $171K | Buy |
8,612
+2,058
| +31% | +$35.6K | ﹤0.01% | 2641 |
|
|
2024
Q4 | $112K | Sell |
6,554
-37,638
| -85% | -$708K | ﹤0.01% | 2645 |
|
|
2024
Q3 | $883K | Sell |
44,192
-319,550
| -88% | -$4.97M | ﹤0.01% | 1181 |
|
|
2024
Q2 | $4.07M | Buy |
363,742
+352,320
| +3,085% | +$2.96M | 0.03% | 646 |
|
|
2024
Q1 | $75K | Sell |
11,422
-81,814
| -88% | -$447K | ﹤0.01% | 2632 |
|
|
2023
Q4 | $421K | Buy |
93,236
+75,213
| +417% | +$278K | ﹤0.01% | 1586 |
|
|
2023
Q3 | $65K | Buy |
+18,023
| New | +$69.4K | ﹤0.01% | 2886 |
|
|
2023
Q2 | – | Sell |
-58,507
| Closed | -$194K | – | 2228 |
|
|
2023
Q1 | $194K | Buy |
58,507
+29,327
| +101% | +$101K | ﹤0.01% | 2434 |
|
|
2022
Q4 | $113K | Sell |
29,180
-113,291
| -80% | -$349K | ﹤0.01% | 2638 |
|
|
2022
Q3 | $346K | Buy |
142,471
+96,048
| +207% | +$230K | 0.01% | 1870 |
|
|
2022
Q2 | $92K | Buy |
+46,423
| New | +$91.3K | ﹤0.01% | 3147 |
|
|
2021
Q2 | – | Sell |
-18,968
| Closed | -$33K | – | 2817 |
|
|
2021
Q1 | $33K | Sell |
18,968
-4,242
| -18% | -$9.71K | ﹤0.01% | 3188 |
|
|
2020
Q4 | $45K | Buy |
+23,210
| New | +$48.8K | ﹤0.01% | 3152 |
|
|
2020
Q3 | – | Sell |
-118,200
| Closed | -$346K | – | 2650 |
|
|
2020
Q2 | $346K | Sell |
118,200
-7,560
| -6% | -$21.7K | ﹤0.01% | 2412 |
|
|
2020
Q1 | $362K | Buy |
+125,760
| New | +$435K | ﹤0.01% | 2089 |
|
Other funds holding ADMA
VCM
VPM
N